Temporal lobe surgery in Germany from 1988 to 2008: Diverse trends in etiological subgroups

European Journal of Neurology

Volumn 21, Issue 6, 2014, Pages 827-834

  Helmstaedter, C ^a   May, T W ^b   von Lehe, M ^c   Pfaefflin, M ^b   Ebner, A ^b   Pannek, H W ^b   Elger, C E ^a   Stefan, H ^a   Schramm, J ^d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b EPILEPSY CENTER BETHEL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Disease modification; Epidemiology; Epilepsy; Hippocampal sclerosis; Pathology

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; COHORT ANALYSIS; CORTICAL DYSPLASIA; DISEASE DURATION; EPILEPTOGENESIS; GERMANY; GLIOSIS; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEMPORAL LOBE EPILEPSY; TIME TO TREATMENT; TREND STUDY; ADOLESCENT; BRAIN NEOPLASMS; CHILD; CLINICAL TRIAL; EPILEPSY, TEMPORAL LOBE; FEMALE; INFANT; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUROSURGERY; PATHOLOGY; PRESCHOOL CHILD; SCLEROSIS; SURGERY; TEMPORAL LOBE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPILEPSY, TEMPORAL LOBE; FEMALE; GERMANY; HUMANS; INFANT; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SCLEROSIS; TEMPORAL LOBE; YOUNG ADULT;

EID: 84899894991     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12322     Document Type: Article

References (23)

1. Wieser HG. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004; 45: 695-714.
2. Olafsson E, Hauser WA, Ludvigsson P, Gudmundsson G. Incidence of epilepsy in rural Iceland: a population-based study. Epilepsia 1996; 37: 951-955.
3. Kjartansson O, Olafsson E, Luovigsson P. Myndgreiningarransoknnir hja flogaveikum yoisrannaokn a Islandi. Leknablat 2002; 88: 86.
4. Berg AT, Vickrey BG, Testa FM, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol 2006; 60: 73-79.
5. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology 2003; 60: 186-190.
6. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311-318.
7. Schiltz NK, Koroukian SM, Lhatoo SD, Kaiboriboon K. Temporal trends in pre-surgical evaluations and epilepsy surgery in the U.S. from 1998 to 2009. Epilepsy Res. 2013 103: 270-278.
8. Englot DJ, Ouyang D, Garcia PA, Barbaro NM, Chang EF. Epilepsy surgery trends in the United States, 1990-2008. Neurology 2012; 78: 1200-1206.
9. Neligan A, Haliasos N, Pettorini B, Harkness WF, Solomon JK. A survey of adult and pediatric epilepsy surgery in the United Kingdom. Epilepsia 2013; 54: e62-e65.
10. Ebner A. Mitteilungen der Arbeitsgemeinschaft für prächirurgische Epilepsiediagnostik und operative Epilepsietherapie. Z Epileptol. 2004 17: 320-322.
11. Schramm J. Entwicklung der Epilepsiechirurgie in Deutschland. Bundesministerium für Gesundheit (ed) Modelle zur Versorgung schwer behandelbarer Epilepsien. Baden-Baden: Nomos, 2000: 37-42.
12. Von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry 2002; 73: 643-647.
13. Choi H, Carlino R, Heiman G, Hauser WA, Gilliam FG. Evaluation of duration of epilepsy prior to temporal lobe epilepsy surgery during the past two decades. Epilepsy Res 2009; 86: 224-227.
14. Annegers JF, Hauser WA, Lee JR, Rocca WA. Secular trends and birth cohort effects in unprovoked seizures: Rochester, Minnesota 1935-1984. Epilepsia 1995; 36: 575-579.
15. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34: 453-468.
16. Sillanpaa M, Lastunen S, Helenius H, Schmidt D. Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23-year registry study. Epilepsia 2011; 52: 1857-1867.
17. Hull J, Dodd KL. Falling incidence of hypoxic-ischaemic encephalopathy in term infants. Br J Obstet Gynaecol 1992; 99: 386-391.
18. Sillanpaa M, Kalviainen R, Klaukka T, Helenius H, Shinnar S. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res 2006; 71: 206-215.
19. Scantlebury MH, Heida JG. Febrile seizures and temporal lobe epileptogenesis. Epilepsy Res 2010; 89: 27-33.
20. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
21. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67: 470-478.
22. Willmore LJ. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav 2005; 7(Suppl. 3): S25-S28.
23. Frisch C, Kudin AP, Elger CE, Kunz WS, Helmstaedter C. Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent. Epilepsy Res 2007; 73: 173-180.